Research articlePublished 30 Jun 2014
The research on growth evaluation of Chinese bio-pharmaceutical listed companies based on factor analysis and entropy method
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
With the development of China’s economy and the evolution of medical insurance system, bio-pharmaceutical has become an industry experiencing rapid development. In this situation, it is of great importance to evaluate the growth ability of bio-pharmaceutical listed companies in order to boost its stable growth. The concepts of factor analysis and entropy method are first defined in the first part. Then, this paper explores the key factors that affect the growth capacity of Chinese bio-pharmaceutical listed companies most by using factor analysis and entropy method. As a result, these influential elements can be summed up as growth equality factor;risk factor;growth efficiency factor and innovation factor. Finally, some reasonable suggestions are presented to escort the sustainable development of Chinese bio-pharmaceutical listed companies .
Subjects
Pharmaceutical SciencesChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Chemical and Pharmaceutical Research
- SubjectPharmaceutical Sciences
- SubjectChemistry
- BylineArticles whose byline prints “Yu-jin Fu”
- BylineArticles whose byline prints “Ju-qin Shen”